Investigating the relationship between totipotency and epigenetic reprogramming during the formation of induced pluripotent stem cells
Active Grant Awarded
- Award ID
- K99GM162991
- Recipient
-
University Of California Santa Cruz UEI VXUFPE4MCZH5
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $125,000
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 9% complete
- Place of performance
- Santa Cruz, CA 95064, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through the National Institute of General Medical Sciences, awarded University of California Santa Cruz $125,000 on September 17, 2026, under Biomedical Research and Research Training (CFDA 93.859), as grant K99GM162991. The award funds basic research into how transient totipotent-like cells and DNA demethylation dynamics contribute to forming induced pluripotent stem cells (iPSCs), with the goal of identifying the minimal molecular pathways that must be activated to form them. Three aims carry this work: lineage tracing of the contribution of transient totipotent-like cells to iPSC colony formation; mapping the DNA methylation-demethylation landscape of these and other reprogramming intermediates; and determining the principles of cell fate conversion during somatic reprogramming of fibroblasts. The source describes this as a K99/R00 award, and its training component provides advanced quantitative microscopy and single-cell technologies, with mentorship from Dr. Shariati in single-cell omics, live imaging, CRISPR, and lentivirus tools. The award carries an obligated amount of $125,000, a period of performance from September 17, 2026 through August 31, 2028, and a place of performance in Santa Cruz, CA 95064, USA. The program supports basic research that advances understanding of biological processes and provides the foundation for disease diagnosis, treatment, and prevention.
Description
- Abstract
- Somatic reprogramming is an inefficient protocol to convert adult cells into embryonic-like cells called induced pluripotent stem cells (IPSCS). This inefficiency is caused by molecular roadblocks that prime only a small proportion of successful intermediate fates to undergo proper epigenetic reprogramming and form IPSCS. However, little is known about these primed intermediate cell fates and the molecular mechanism leading to an efficient epigenetic reprogramming. My preliminary results identified a reprogrammable intermediate state termed transient totipotent-like cells (ITTCS) characterized by the expression of totipotency markers like DPPA3, CCNA1, and TPRX1. To build upon these preliminary results, I propose to investigate how totipotent intermediates contribute to the formation of IPSCS and how DNA demethylation dynamics progress throughout somatic reprogramming. In aim 1, I will elucidate, by lineage tracing, the contribution of ITTCS to the formation of IPSCS colonies. In aim 2, I will investigate the DNA methylation-demethylation landscape of ITTCS and other reprogramming intermediates. In aim 3, I will determine the principles of cell fate conversion during somatic reprogramming of fibroblasts. By capitalizing on my expertise in cell biology, stem cell biology, and embryology, and expanding upon bioengineering and single-cell omics, I aim to identify the minimal molecular pathways that need to be activated to form IPSCS. This K99/R00 award will provide a unique opportunity for research and training on advanced quantitative microscopy and single-cell technologies that will deeply impact my academic career. The training during my K99 phase will be enhanced by the expertise of my mentor, DR. Shariati, in diverse methodologies in single-cell omics, live imaging, crispr, and lentivirus tools. In addition, with the expertise from my career mentors DR. Sharma, DR. Hinck, DR. Nicholas, and DR. Forsberg, I will be tackling faculty applications in parallel to my research. My ultimate goal is to recruit and retain a broad scientific workforce by creating a supportive and intentional research culture where budding scientists from all types of backgrounds can safely connect and collaborate to understand epigenetic reprogramming, cell fate transitions, and acquisition of pluripotency. In the future, my research questions will use various well-optimized molecular and cellular biology techniques, including single- cell live imaging, single-cell omics, crispr and self-replicating RNA technologies, microinjection, and more. The tools and knowledge developed during my K99 award could be applied to a wide range of developmental biology questions and will enhance my lab's ability to study key developmental events, including network robustness, cell signaling, symmetry breaking, and multipotency.
Quick answers
Who received award K99GM162991?
K99GM162991 was awarded to University Of California Santa Cruz by National Institute of General Medical Sciences (National Institutes of Health) on September 17, 2026.
How much is award K99GM162991 worth?
$125,000 has been obligated on K99GM162991.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award